Evidence map›Paper›PMID 40539503›Full record

ArticleMovement disorders clinical practice2025

Constipation in a Large Online Cohort of Persons with Parkinson's Disease.

Adil E Bharucha, Mohammad Ghafouri, Revati Varma, Robert A Vierkant, Muhammad Abdul Rehman, Kent R Bailey, James H Bower, Rodolfo Savica

Abstract read
In one paragraph

Article in Movement disorders clinical practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Adil E BharuchaDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.ORCID https://orcid.org/0000-0002-7644-0390
Mohammad GhafouriResearch Fellow in the Division of Gastroenterology and Hepatology, Mayo Clinic School of Graduate Medical Education, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
Revati VarmaResearch Fellow in the Division of Gastroenterology and Hepatology, Mayo Clinic School of Graduate Medical Education, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
Robert A VierkantDivision of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, Minnesota, USA.
Muhammad Abdul RehmanResearch Fellow in the Division of Gastroenterology and Hepatology, Mayo Clinic School of Graduate Medical Education, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.ORCID https://orcid.org/0000-0003-3540-0998
Kent R BaileyDivision of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, Minnesota, USA.
James H BowerDepartment of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
Rodolfo SavicaDepartment of Neurology, Mayo Clinic, Rochester, Minnesota, USA.ORCID https://orcid.org/0000-0002-2543-0627

Funding

Mayo Clinic Consortium for Gut Brain Communication in Parkinson's DiseaseU01DK140921 · NIDDK · MAYO CLINIC ROCHESTER · PI ADIL E. BHARUCHA, Rodolfo Savica · 2024 to 2026
$2.4M
Michael J. Fox Foundation for Parkinson's ResearchNIDDK NIH HHS RO1 DK 140921NIDDK NIH HHS U01 DK140921
6 · The paper itself

Abstract

backgroundSmall studies suggest that constipation is a common symptom associated with a worse prognosis in patients with Parkinson's disease (PD).

objectivesThe aim was to compare the association between constipation, motor, and other non-motor symptoms (NMS) in PD patients at baseline and in future.

methodsUsing the Fox Insight database, we compared baseline characteristics, risk of progressive motor symptoms, and incidence of NMS between PD patients with versus without constipation.

resultsOf 20,352 participants, 16,611 (82%) reported infrequent bowel movements and/or excessive straining, 15,594 (77%) had incomplete evacuation, and 14,165 (70%) reported both symptoms. Patients with constipation were generally older, white, women, had PD >5 years, and had higher NMS and comorbidity scores (P < 0.001). Constipation was significantly associated with worse motor symptoms and most NMS, especially fecal incontinence (odds ratio [OR] = 1.65; 95% confidence interval [CI], 1.49-1.82), dysphagia (OR = 1.20; 95% CI = 1.12-1.29), talking/moving during sleep (OR = 1.39; 95% CI = 1.30-1.48), and urinary urgency (OR = 1.23; 95% CI = 1.16-1.32). Constipation was associated with a small, but statistically significant increased risk of some progressive motor symptoms. At a mean median follow-up of 2.8 years, constipation was associated with an increased risk of incident gastrointestinal, autonomic, neuropsychiatric, sleep-related, sensory NMS, such as dysphagia (hazard ratio [HR] = 1.43; 95% CI = 1.35-1.51), fecal incontinence (HR = 1.87; 95% CI = 1.74-2.01), falls (HR = 1.44; 95% CI = 1.35-1.52), hallucinations (HR = 1.65; 95% CI = 1.52-1.79), cognitive impairment (HR = 1.38; 95% CI = 1.30-1.47), and talking/moving during sleep (HR = 1.65; 95% CI = 1.55-1.75).

conclusionsConstipation is a common symptom associated with severity of motor and other NMS and portends a worse prognosis in persons with PD.

Indexed as

ConstipationParkinson DiseaseAgedAged, 80 and overCohort StudiesFemaleHumansMaleMiddle Ageddysphagia; epidemiology; fecal incontinence; natural history; parkinsonism

Identifiers

PMID40539503
PMCPMC12715370

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.